Topics
Cystoid Macular Edema
Diabetic Retinopathy
Genetics and Nutrition in Retinal Disease
Emerging Data to Guide Clinical Decisions: Treating the AMD Patient
This continuing medical education activity is supported by an unrestricted educational grant from Genentech Inc.
View Supplement
Next-Generation OCT Technology
A Multi-Disciplinary Approach to the Management of Cystoid MacularEdema
This continuing medical education activity is supported by an unrestricted educational grant from Allergan, Inc.
Vitreoretinal Surgery
Clinical Cases: NSAIDs for CME
This continuing medical education activity is supported by an unrestricted educational grant from Alcon Laboratories.
View Insert
FIELD Study Revealed Fenofibrate Reduced Need for Laser Treatment for Diabetic Retinopathy
This continuing medical education activity is supported by an unrestricted educational grant from Abbott Laboratories.
Combination Therapy for AMD
Implementing New Data to Treat the AMD Patient
This continuing medical education activity is supported by an unrestricted educational grant from Genentech.
Free Print Subscription
Email Newsletter
Conference Calendar
June 24, 2026
Kalaris to Present Phase 1a Data on VEGF/HSPG Biologic at ASRS 2026
Ollin Biosciences Raises $330 Million to Advance Phase 3 Development of VEGF/Ang2 bispecific Antibody
June 23, 2026
Oculgen Announces First US Patient Enrolled in STAT Trial of OCUL101 for Wet AMD
June 22, 2026
Atsena Doses First Patient in Phase 3 LIGHTHOUSE Trial of Gene Therapy for XLRS